BofA Securities analyst Travis Steed lowered the price target on Abbott Labs (NYSE: ABT) to $120.00 (from $150.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE